U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Friday.
Shares of Asana, Inc. ASAN rose sharply during Friday's session after the company announced a $150 million share repurchase program and reaffirmed its forward guidance.
Asana said its board of directors approved a stock repurchase program authorizing the company to repurchase up to $150 million of its Class A common stock through June 30, 2025.
Asana shares jumped 13.4% to $12.90 on Friday.
Here are some other big stocks recording gains in today’s session.
- Sarepta Therapeutics, Inc. SRPT shares jumped 39.2% to $171.89 after the company announced FDA approval of an expansion to the labeled indication for ELEVIDYS to include individuals with Duchenne muscular dystrophy with a confirmed mutation in the DMD gene who are at least 4 years of age. Also, multiple firms raised their respective price targets on the stock.
- Clover Health Investments, Corp. CLOV shares gained 31% to $1.35 following insider buying from the company's co-founder. After the market close on Thursday, Clover Health filed a Form 4 with the SEC showing that co-founder and executive chair Vivek Garipalli purchased 877,567 shares of Clover Health stock at an average price of $1.14 per share.
- Avid Bioservices, Inc. CDMO climbed 13.7% to $7.75.
- Cabaletta Bio, Inc. CABA rose 9.1% to $9.09.
- ADTRAN Holdings, Inc. ADTN climbed 8.7% to $5.65
- Hertz Global Holdings, Inc. HTZ gained 8.6% to $3.8150. The company revealed the upsize and pricing of $1 billion offerings, which comprised $750 million of First Lien Senior Secured Notes, which represents an upsize from the previously announced $500 million.
- Studio City International Holdings Limited MSC rose 8% to $6.75.
- Codere Online Luxembourg, S.A. CDRO gained 7.6% to $7.80.
- Methode Electronics, Inc. MEI jumped 7.1% to $10.74.
- Ironwood Pharmaceuticals, Inc. IRWD gained 6.5% to $5.94. Ironwood Pharmaceuticals named Sravan K. Emany as Senior Vice President, Chief Operating Officer, and Chief Financial Officer.
- Enviri Corporation NVRI rose 6% to $8.86.
- PTC Therapeutics, Inc. PTCT gained 5.4% to $35.08. B of A Securities analyst Tazeen Ahmad maintained PTC Therapeutics with an Underperform and raised the price target from $25 to $32.
- Spirit AeroSystems Holdings, Inc. SPR rose 4.8% to $33.19. Boeing Co. BA is reportedly close to finalizing a deal to reacquire Spirit AeroSystems, its former subsidiary, following significant progress in separate negotiations between Spirit and Airbus SE EADSY to divide Spirit's projects between the two aerospace giants.
Now Read This: Wall Street’s Most Accurate Analysts Spotlight On 3 Tech And Telecom Stocks Delivering High-Dividend Yields
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.